Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 381–400 · 1918 ms
Cattell W R, Taylor G W·American heart journal
Abstract not available
McCauley C R, Weil A T·Science (New York, N.Y.)
Abstract not available
Clyne M B, Freeling P, Ginsborg S·The Practitioner
Abstract not available
Hays P·Lancet (London, England)
Abstract not available
Hakkarainen H·Headache
Abstract not available
Maslansky L, Wein G·JAMA
Abstract not available
Shapiro A K·The Journal of clinical pharmacology and the journal of new drugs
Abstract not available
Balla J I·Lancet (London, England)
Abstract not available
White S J, Freedman L S·British journal of cancer
In a controlled clinical study ("clinical trial") to compare 2 or more treatments for a disease, an objective method of allocating patients to treatment groups is needed. Various existing methods of allocation are described, including those which take account of patients' pre-treatment characteristics.
Sunahara S·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Abstract not available
Peng Bao Gang, Liu Shu Qin, Kuang Ming, +8 more·Japanese journal of cancer research : Gann
We developed a tumor vaccine consisting of fixed hepatocellular carcinoma (HCC) cells/tissue fragments, biodegradable microparticles encapsulating granulocyte-macrophage-colony stimulating factor and interleukin-2, and an adjuvant. The vaccine protected 33% of syngeneic mice from HCC cell challenge. The vaccine contain…
Carroll D, Lewis S A, Oswald I·Nature
Abstract not available
Klein D L·Pediatrics
Abstract not available
Psychopharmacology bulletin
Abstract not available
Clyne M B, Freeling P, Ginsborg S·The Practitioner
Abstract not available
Geissler C, Horton T·Lancet (London, England)
Abstract not available
Arfai E, Theano G, Montagu J D, +1 more·The British journal of psychiatry : the journal of mental science
Abstract not available
Shusterman N H·Delaware medical journal
Abstract not available
Bross Peter F, Kane Robert, Farrell Ann T, +18 more·Clinical cancer research : an official journal of the American Association for Cancer Research
Abstract not available
Boisjolie C R, Sharkey S W, Cannon C P, +4 more·The American journal of cardiology
Because time to treatment in AMI is a critical factor in long-term outcome, it is important that complex trials designed to improve reperfusion therapy do not delay the time to treatment. Participation in the TIMI 5 trial did not significantly prolong our door-to-needle time. These results indicate that, if done carefu…